Shi Yanzhi
Directeur/Membre du Conseil chez SCIGEN LIMITED
Profil
Shi Yanzhi is currently a Director at SciGen Pte Ltd.
Prior to this, they obtained an MBA from the University of Glasgow.
Postes actifs de Shi Yanzhi
| Sociétés | Poste | Début |
|---|---|---|
| SCIGEN LIMITED | Directeur/Membre du Conseil | 08/08/2018 |
Formation de Shi Yanzhi
| University of Glasgow | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
SciGen Pte Ltd.
 SciGen Pte Ltd. Pharmaceuticals: MajorHealth Technology SciGen Pte Ltd. engages in the development, manufacturing, and marketing of biopharmaceutical products. It operates through following segments: Singapore, Australia, Korea, Thailand, Philippines, China, and Others. The Singapore segment comprises of corporate office functions, sales, and marketing. The Australia, Korea, Thailand, and Philippines segments deal with sales and marketing activities. The China segment is involved in regulatory activities. The Others segment covers operations on in Indonesia, Pakistan, Vietnam, Hong Kong, Myanmar, Malaysia, and profit sharing income on sale of insulin. The firm's products include SciLin, SciTropin A, SciLocyte, SciTrace 5 Injection, and Heri Injection. The company was founded by Saul Akerib Mashaal in 1988 and is headquartered in Singapore. | Health Technology |
